The company is privately held and backed by a diverse group of professional investors – including the founders, the renowned cancer incubator Radforsk and the Norwegian investment company Investinor.

Hubro Therapeutics suggests that investors who wish to stay informed and follow the company’s progression subscribes to the newsletter.

Top ten investors

 NameOwnership %
1Timmuno AS17,47
2Investinor Direkte AS16,97
3Canica Holding AG16,09
4Jandersen Kapital AS10,71
6Algot Invest AS8,11
7Integrated Innovation Consulting LLP5,19
8Morthen Thorsen Holding AS2,10
9JAG Holding AS1,93
10Vikingen AS1,93
Scroll to see the full table →

Investor relations

Inquiries can be made to the company´s IR:

Jon Amund Eriksen, CEO
Phone: +47 95085914

This website uses cookies to ensure you get the best experience on our website.